Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |